Zhuoer Xie,Rami S Komrokji,Najla Al-Ali,Alexandra Regelson,Susan Geyer,Anand A Patel,Caner Saygin,Amer M. Zeidan,Jan Philipp Bewersdorf,Lourdes M Mendez,Ashwin Kishtagari,Joshua F. Zeidner,Catherine C. Coombs,Yazan F Madanat,Stephen S Chung,Talha Badar,James M Foran,Pinkal Desai,Charlton Tsai,Elizabeth A. Griffiths,Monzr M. Al Malki,Idoroenyi Amanam,Catherine Lai,H. Joachim Deeg,Lionel Ades,Cecilia Arana-Yi,Afaf EG Osman,Shira Naomi Dinner,Yasmin Abaza,Justin Taylor,Namrata S Chandhok,Deborah Soong,Andrew M. Brunner,Hetty E Carraway,Abhay Singh,Chiara Elena,Jacqueline Ferrari,Anna Galli,Sara Pozzi,Eric Padron,Mrinal M. Patnaik,Luca Malcovati,Michael R. Savona,Aref Al-Kali

Abstract:Clonal cytopenia of undetermined significance (CCUS) represents a distinct disease entity characterized by myeloid-related somatic mutations with a variant allele fraction of ≥2% in individuals with unexplained cytopenia(s) but without a myeloid neoplasm (MN). Notably, CCUS carries a risk of progressing to MN, particularly in cases featuring high-risk mutations. Understanding CCUS requires dedicated studies to elucidate its risk factors and natural history. Our analysis of 357 CCUS patients...

Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence